CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 75 filers reported holding CUE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $67 | -74.3% | 18,269 | -75.0% | 0.01% | -73.1% |
| Q1 2023 | $261 | -51.4% | 73,111 | -61.2% | 0.03% | -61.2% |
| Q4 2022 | $537 | -99.9% | 188,308 | -12.9% | 0.07% | +4.7% |
| Q3 2022 | $482,000 | +49.2% | 216,250 | +66.8% | 0.06% | +33.3% |
| Q2 2022 | $323,000 | -31.4% | 129,666 | +34.3% | 0.05% | -23.8% |
| Q1 2022 | $471,000 | -58.3% | 96,563 | -3.3% | 0.06% | -55.6% |
| Q4 2021 | $1,129,000 | -36.4% | 99,816 | -18.0% | 0.14% | -21.5% |
| Q3 2021 | $1,774,000 | +436.0% | 121,727 | +328.7% | 0.18% | +389.2% |
| Q2 2021 | $331,000 | +113.5% | 28,396 | +124.2% | 0.04% | +42.3% |
| Q1 2021 | $155,000 | -80.7% | 12,666 | -80.3% | 0.03% | -80.3% |
| Q4 2020 | $804,000 | +19.3% | 64,297 | +43.5% | 0.13% | +17.9% |
| Q3 2020 | $674,000 | – | 44,801 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,510,282 | $7,370,000 | 4.76% |
| SANDERS MORRIS HARRIS LLC | 873,021 | $4,261,000 | 0.83% |
| P.A.W. CAPITAL CORP | 150,000 | $732,000 | 0.76% |
| Nantahala Capital Management | 2,244,359 | $10,952,000 | 0.48% |
| Bleichroeder LP | 552,000 | $2,694,000 | 0.48% |
| APOGEM CAPITAL LLC | 111,259 | $543,000 | 0.37% |
| Slate Path Capital LP | 1,483,619 | $7,240,000 | 0.37% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $2,335,000 | 0.20% |
| CARLSON CAPITAL L P | 405,000 | $1,976,000 | 0.14% |
| Bridgefront Capital, LLC | 19,968 | $97,000 | 0.12% |